← back to search

Jie Zhang

Jiangxi University of Traditional Chinese Medicine · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, Circular RNAs in diseases, MicroRNA in disease regulation, and Asthma and respiratory diseases.
h-index
37
citations
4,881
works
210
NIH funding
primary concept
email

Recent publications

Impact of prolonged infection on SARS-CoV-2 evolution.
2026cited by 0position: contributordoi
Oral Administration of Ovalbumin Prevents Food Allergy via Improving Microbiota and Metabolic Disorders in a Dose-Dependent Manner
Journal of Agricultural and Food Chemistry 2025cited by 5position: middledoi
NF-<i>κ</i>B: a mediator that promotes or inhibits angiogenesis in human diseases?
Expert Reviews in Molecular Medicine 2023cited by 19position: middledoi
FSCV/ECL dual-mode detection of circulating tumor cells based on multi-functionalized 2D bionanomaterials
Sensors and Actuators B Chemical 2023cited by 15position: middledoi
Roles of sirtuin family members in chronic obstructive pulmonary disease.
2022cited by 31position: contributordoi
Asthma Management Using the Mobile Asthma Evaluation and Management System in China
Allergy Asthma and Immunology Research 2022cited by 10position: middledoi
Clinical Phenotypes With Prognostic Implications in Pulmonary Embolism Patients With Syncope
Frontiers in Cardiovascular Medicine 2022cited by 9position: middledoi
Asthma Management Using the Mobile Asthma Evaluation and Management System in China.
2022cited by 8position: contributordoi
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study
Thrombosis Journal 2022cited by 8position: middledoi
Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis
Human Cell 2022cited by 7position: firstdoi
LINC00467 induces melanoma deterioration by targeting miR-485-5p/p21 activated kinase 1
Journal of Medical Biochemistry 2022cited by 2position: middledoi
Treatable Traits in Elderly Asthmatics from the Australasian Severe Asthma Network: A Prospective Cohort Study
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 34position: middledoi
Screening of anti-allergy Lactobacillus and its effect on allergic reactions in BALB/c mice sensitized by soybean protein
Journal of Functional Foods 2021cited by 27position: middledoi
miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin
Anti-Cancer Drugs 2021cited by 16position: middledoi
Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function.
2021cited by 7position: contributordoi
Long non-coding RNA GHET1 promotes thyroid cancer cell proliferation and invasion
Translational Cancer Research 2021cited by 4position: middledoi
Acetylbritannilactone attenuates contrast-induced acute kidney injury through its anti-pyroptosis effects
Bioscience Reports 2020cited by 24position: middledoi
Cigarette Smoke Induced Lung Barrier Dysfunction, EMT, and Tissue Remodeling: A Possible Link between COPD and Lung Cancer.
2019cited by 118position: contributordoi
Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.
2019cited by 93position: contributordoi
Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer.
2019cited by 28position: contributordoi
Genetic variant of TMBIM1 is associated with the susceptibility of colorectal cancer in the Chinese population
Clinics and Research in Hepatology and Gastroenterology 2018cited by 10position: firstdoi
Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer
Oncotarget 2016cited by 57position: middledoi
Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer
Journal of Experimental & Clinical Cancer Research 2015cited by 102position: middledoi
FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer
Clinical Cancer Research 2014cited by 158position: middledoi
Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer
Current Medical Research and Opinion 2014cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xin Li · South China Agricultural University2 papers (2021–2025)Ling Zhang · Hebei Medical University1 papers (2015–2015)Cuizhi Geng · Hebei Medical University1 papers (2021–2021)Lili Zhang · Chinese Academy of Sciences1 papers (2022–2022)Yaqiong Jin · Hebei Medical University1 papers (2020–2020)Chunli Zhang · Zhejiang Chinese Medical University1 papers (2022–2022)Hongbing Chen · Deutsches Historisches Institut Washington1 papers (2025–2025)Lei Shen · Yangtze Optical Electronic (China)1 papers (2014–2014)Zhongliang Wang · Guangdong Ocean University1 papers (2025–2025)Jianlong Wang · Columbia University Irving Medical Center1 papers (2022–2022)Ping Shi · Qujiang People's Hospital1 papers (2021–2021)Yunxia Zhang · Jiangnan University1 papers (2022–2022)Yuan Li · Shihezi University1 papers (2014–2014)Min Xie · Ministry of Education of the People's Republic of China1 papers (2021–2021)Ting Ye · Fudan University1 papers (2014–2014)Jie Luo · University of Rochester Medical Center1 papers (2015–2015)Haiquan Chen · Shanghai Medical College of Fudan University1 papers (2014–2014)Dingyi Wang · Fujian Normal University1 papers (2022–2022)GU Li-xiong · Nantong University1 papers (2022–2022)Shengju Yang · Nantong University1 papers (2022–2022)